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ABSTRACT
-Terpineol is a natural compound of terpenoid alcohols class. However, it can be synthesized
from -pinene of turpentin content. -Terpineol has been reported as potential anticancer agent
due to its activity on inhibition of cells growth and induction of tumor cell death. However, its
anticancer activity in HeLa cervical cancer cells line has never been studied, yet. The aim of this
study was to evaluate the cytotoxicity of -terpineol and its effects to apoptosis and cell cycle.
This was a quasi-experimental study with post-test only with non-equivalent control group
design. Cytotoxicity of á-terpineol was evaluated using MTT cell viability assay. The effect of -
terpineol on cell apoptotis was tested using acridine orange-ethidium bromide staining method,
whereas its effect on cell cycle was evaluated by flowcytometry method. The results showed
that -terpineol had cytotoxicity against HeLa cell with an IC 50 value about 12.46 g/mL.
Furthermore,-terpineol induced the HeLa with an IC50 value about 13.12g/mL. Cell accumulation
at G1 phase during cell cycle after incubation with-terpineol (52.78) was observed. In conclusion,
-terpineol is potential as an anticancer due to its ability to induce cell apoptosis and to inhibit
the cell cycle at G1 phase.
ABSTRAK
-Terpineol adalah senyawa bahan alam golongan alkohol terpenoid. Namun demikian senyawa
ini telah berhasil disintesis dari -pinen dalam terpentin. -Terpineol dilaporkan sebagai antikanker
potensial karena aktivitasnya dalam menghambat pertumbuhan sel dan menginduksi kematian
sel tumor. Namun demikian, aktivitas antikankernya pada sel kanker serviks HeLa belum pernah
diteliti. Tujuan penelitian ini adalah mengkaji sitotoksisitas -terpineol dan efeknya pada apoptosis
dan siklus sel. Penelitian ini merupakan penelitian eksperimental kuasi dengan rancangan quasi-
experimental study with post-test only with non-equivalent control group. Sitotoksisitas -
terpineol dikaji dengan penetapan viabilitas sel MTT. Efek -terpineol terhadap apoptosis sel
diuji dengan metode pengecatan acridine orange-ethidium bromide, sedangkan efeknya pada
siklus sel diuji dengan metode flowsitometri. Hasil penelitian menunjukkan-terpineol mempunyai
sitotoksisitas melawan sel HeLa dengan nilai IC50 sekitar 13.12 g/mL. Akumulasi sel pada fase
G1 selama siklus sel setelah inkubasi dengan - terpineol (52.78) dijumpai dalam penelitian.
Dapat disimpulkan, -terpineol potensial sebagai antikanker karena efeknya dalam menginduksi
apoptosis dan menghambat siklus sel pada fase G1.
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INTRODUCTION
Cancer remains a major health problem in
the world, both in developed and developing
countries. World Health Oganization (WHO)
and World Bank estimate that 12 millions people
worldwide suffer from cancer annually and 7.6
millions of them died.1 The high incidence and
mortality of cancer patients are currently due to
low rate of the success of treatments. Various
methods against the cancer have been developed
including surgery, radiation, immunotherapy,
and chemotherapy. However, the success rate
of the methods is still low due to its dis-
advantages.2 This situation encourages the
efforts to discover and develope anticancer that
more effective and sensitive without serious side
effects.3
Various strategies have been conducted in
the discovery of anticancer agents including
isolating active compounds from natural
materials. The compound that is currently
widely studied and developed as an anticancer
agent is terpenoids.4 One of terpenoids derived
from natural ingredients is terpineol. Terpineol
is produced by various plants such as eucalyptus
(Melaleuca leucadendra), pine (Pinus sp.) and
limes (Citrus aurantifolia).5 It also can be
synthesized from-pineneof turpentine which
is derived from extract of sap of pine trees
(Pinus merkusii).6 Terpineol can be synthesized
into -terpineol which is reported to have
potential as anticancer agents. Synthesis of-
terpineol from P. merkusii that was grown in
Indonesia was successfully conducted by
Budiman.7
-Terpineol has been reported as a natural
compound that has a potential anticancer
activity. This compound has been reported to
inhibit growth and induce tumor cell death by
inhibiting the activity of NF-kB.8 NF-kB is a
transcription factor that plays role in the
regulation of gene expression of apoptosis,
replication, tumorigenesis, inflammation and
autoimmune diseases. NF-kB can be stimulated
in the presence of growth factors, cytokines,
lymphokines, radiation, pharmacologic agents,
and stress.9
Cancer cell proliferation occurs beyond
normal limits and it is uncontrolled. This is due
to the disruption of cell cycle, the increase of
angiogenesis and suppression of apoptosis.10
Apoptosis is a form of cell death designed to
eliminate unwanted host cells. The process of
apoptosis is programmed through a series of
events involving a set of gene products.
Apoptosis is responsible for physiological and
pathological processes. In pathological process,
apoptosis plays a major role in tumor cell
death.11
A specific feature of apoptosis is hydrolysis
process that involves some classes of caspase.
Caspase triggers endonuclease activity which
breaks nucleus and cytoskeletal proteins seen
in apoptotic cells. The DNA of apoptotic cells
shows a typical fraction size of 50 – 300 kbp.
Furthermore, there is a degradation of
internucleosomal DNA by endonucleases into
oligonucleosome in various sizes between 120
– 200 bp. In agarose gel electrophoresis, they
appear as fragments of DNA ladder.10,11
Cancer cells are capable of avoiding
apoptosis.11 Activation of apoptosis, both in
extrinsic and intrinsic pathways, will lead to
activation of caspase-3 as an executioner
caspase. When caspase-3 is activated, cell death
(to commit suicide) or apoptosis is inevitable.
Many new therapeutic methods were developed
with the aim of spurring cancer cell apoptosis
by activating apoptotic cascade. However,
cancer cells that have variety of mutations can
avoid this apoptotic cascade.12
HeLa cells are epithelial cells derived from
cervical adenocarcinoma of humans infected
with human papilloma virus (HPV) 18. The HPV
18 virus expresses two oncogenes, E6 and E7.
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The E6 protein binds to tumor suppressor
proteins p53 which accelerates degradation,
whereas the E7 protein binds to the active form
of Rb family. This bond causes the
destabilization of Rb and breaks the Rb/E2F
complexes that play role in suppressing
transcription of genes required for cell cycle
progression.13,14
The activity of -terpineol in cervical
cancer cells (HeLa) has never been studied, yet.
Therefore, this study was conducted to evaluate
the cytotoxicity of-terpineol in HeLa cells.
Furthermore, this study also aimed to examine
whether the death of HeLa cells is caused by
apoptotic process and how it affects the cell
cycle.
MATERIALS AND METHODS
Materials
This was a quasi-experimental study using
post-test only with non-equivalent control group
design. This study was conducted on HeLa cells
after incubated with -terpineol. The -
terpineol was obtained and synthesized by Prof.
Dr.Arif Budiman of the Department of Chemical
Engineering, Universitas Gadjah Mada. HeLa
cells were obtained from the Laboratory of
Parasitology, Faculty of Medicine, Universitas
Gadjah Mada.
Cytotoxicity assay
Cytotoxicity of-terpineol was evaluated
on HeLa cell line using the MTT assay.15 HeLa
cells were distributed in 96-wells microplates
at 1 x 104 cells per well in 100 mL and then 100
mL of complete RPMI 1640 medium were
added. The cell cultures were then incubated in
5% CO2 incubator at 37
oC for 24 hours.
Following after incubation, the medium was
removed and replaced with new complete
RPMI 1640 medium containing various
concentrations of-terpineol (0.38 to 48.20 µg/
mL). The culture and -terpineol were then
incubated again in 5% CO2 incubator at 37
oC
for 24 hours. After the incubation, the medium
was removed and the culture were added 100
mL of RPMI 1640 medium and 10 mL of MTT
[3-9,4,5-dimethylthiazole-2-yl-2,5-diphenyl-
tetrazolium bromide] reagent and then incubated
for 4 hours. The reaction was stopped by adding
100 mL of 10% sodium dodecyl sulfate (SDS)
in 0.01N HCl. Microculture plates were then
shaken gently for 5 minutes, covered with alu-
minium foil and incubated at room temperature
for 12 hours. Absorbance of the microculture
plates was measured in an ELISA plate reader
at595 nm. The percentage of inhibition of
cell growth was obtained by this formula:
Inhibitory Concentration 50% (IC50) i.e.
concentration of -terpineol that inhibit 50%
of cell growth was then determined by probit
analysis. Doxorubicin was used as positive
control in this study.
Apoptotic assay
Apoptosis assay was carried out by examin-
ing the morphology of HeLa cells which were
incubated with-terpineol for 24 hours.16 The
HeLa cells culture in complete RPMI 1640
medium at a final concentration of 5 x 104/mL
were distributed in 24-wells plates coated with
coverslip at the bottom. The cells were then
treated with 1000 µL of -terpineol at a
concentration equivalent with the ½ IC50 (6.23
µg/mL), IC50 (12.46 µg/mL) and 2 x IC50 (24.92
µg/mL) values and incubated in 5% CO 2
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incubator at 37°C for 24 hours. After incubat-
ion, the medium was removed and the cells were
washed gently with PBS. Coverslip containing
the treated cells were removed to glass object
and then stained with 100 µL of mixture of
acridine orange-ethidium bromide in PBS
solution. The cells were observed under a
fluorescence microscope with magnification of
100-200x. The apoptotic cells would emit
brown fluorescence and the viable cells would
emit green fluorescence. The number of
apoptotic cells was calculated in each 100 cells.
The pro-apoptotic ability of -terpineol was
expressed by EC50 which was determined by
probit analysis. Doxorubicin was used as
control.
Cell cycle analysis
Cells cycle analysis was performed using
flowcytrometry. One thousand µL HeLa cell
culture were distributed in 6-well plates at
density of 5 x 105 cells per well and incubated
in 5% CO2 incubator at 37°C overnight. After
overnight incubation, the cells culture were
added 500L of -terpineol at two different
concentrations which were equivalent to the
value of ½ IC50 (3.12 µg/mL) and IC50 (6.23
g/mL) and incubated in 5% CO2 incubator at
37°C for 24 hours. After incubation, the cells
were then collected, harvested and centrifuged.
Cell pellets were washed twice with 500L of
cold PBS and then then incubated with 400L
of propidium iodide reagent at 37°C for 10
minutes and transferred to flowcytotube. The
cells were immediately analyzed by FACS
Calibur flowcytometer to evaluate cell cycle
profile. Flowcytometry data were analyzed with
Cell Quest program to evaluate the cells
distribution in each phase of cell cycle and to
evaluate polyploidy. The cell cycle inhibition
was observed by comparing the cells
distribution of treated and untreated cells.
Statistical analysis
Data were presented as the mean ± standard
deviation (SD). Statistical comparisons were
performed using Student’s t-test. The differences
between groups were considered statistically
significant if a p value of less than 0.05.
RESULTS
The cell growth inhibition of HeLa cells
after incubation with-terpineol or doxorubicin
in various different concentrations is presented
in TABLE 1. After incubation with-terpineol
at concentration 0.38 µg/mL, the cell growth
inhibition percentage was 6.75% and the
inhibition increased along with the increase of
-terpineol concentration. In the highest
concentration (48.20g/mL), the inhibition was
84.45%. The smallest concentration of
doxorubicin (0.75 g/mL), the inhibition was
29.11%, while the largest concentration (100
g/mL), the inhibition was 91.61% of inhibition.
The inhibition increased along with the increase
of doxorubicin concentration. Furthermore, the
cytotoxicity-terpineol (IC50 value of 12.46 ±
13.29g/mL) was lower than doxorubicin (IC50
value of 6.33 ± 0.31g/mL) (p<0.05).
The effect of-terpineol on the apoptosis
of HeLa cell was analyzed using acridine
orange-ethidium bromide staining. The morpho-
logical observation after staining is presented
in FIGURE 1. The apoptotic cells emited brown
fluorescence, whereas the viable cells emited
green fluorescence. The percentage of apoptotic
HeLa cells after treatment with-terpineol is
presented in TABLE 2. The apoptosis ability
of HeLa cells after incubation with-terpineol
was expressed in EC50. The EC50 value after-
terpineol incubation (13.12 ± 7.24 µg/mL) was
significantly higher than after doxorubicin
incubation (5.90 ± 1.25g/mL) (p<0.05). It was
indicated that the effect of -terpineol in cell
apoptotic induction was lower than doxorubicin.
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TABLE 1. The HeLa cell growth inhibition after 24 hours incubation
with -terpineol or doxorubicin and its IC50 value
FIGURE 1. Morphological observation with ethidium bromide-acridin
orange staining incubated of HeLa cells after incubation without
(a) and with -terpineol (b). Viable cells emited brown
fluorescence () and apoptotic cells emited green fluorescence
(). Observation was conducted using fluorescence microscope
with magnification of 100x.
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TABLE 2. The percentage of apoptotic HeLa cells after treatment with -
terpineol for 24 hours
TABLE 3 and FIGURE 2 showed the
number of HeLa cells accumulation in each cell
cycle after incubation with -terpineol. The
incubation with 12.46 g/mL of -terpineol
showed that most of the cells were accumulated
in sub G0/G1 phase, while incubation with 6.23
g/mL of-terpineol showed that most of the
cells were in the G0/G1 phase. Incubation with
doxorubicin also caused the cells to accumulate
in sub G0/G1 phase. The high number of cells
accumulation in sub G0/G1 phase was probably
because most of the cells had undergone
apoptosis.
TABLE 3. Average distribution of HeLa cells in each cell cycle after treatment with -terpineol for 24
hours
FIGURE 2. The distribution of HeLa cells in each cell cycle after incubation
with -terpineol for 24 hours at concentration of 6.23 and 12.46
µg/mL and with doxorubicin at concentration of 6.33 µg/mL/
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DISCUSSION
This study showed that-terpineol inhibited
the HeLa cell growth in a dose-dependent
manner with an IC50 value of 12.46 µg/mL.
America National Cancer Institute classifies a
compound as a potential candidate for
anticancer if it has IC50 value less than 30 µg/
mL.17 Based on this criteria,-terpineol could
be categorized as a potential anticancer
compound. The-terpineol was less active than
doxorubicin as positive control (IC50: 5.90 µg/
mL) in this study. It may be caused the low purity
of -terpineol (51%) that tested. Therefore,
development of synthesis process to obtain high
purity will increase the cytotoxicity of -
terpineol.
Studies concerning cytotoxicity of -
terpineol in various cancer cell lines has been
conducted by some authors. Hasan et al.8
reported that -terpineol was active against
NCI-H69 lung cancer cell line.-Terpineol had
also antiproliferative effects against erythro-
leukemic cell and TD47 breast cancer cell lines
in vitro.18,19
The process of cell death through apoptosis
was important as an indicator of -terpineol
selectivity as a candidate of anticancer agent.
The observation showed that all cells in control
group were in green color which indicated that
no cells death were observed in the control
group. In contrast, incubation with-terpineol
caused some cells to emit brown to red
fluorescence which indicated the beginning of
the loss of cell membrane permeability as an
indicator of apoptosis. Then cell nuclei were
fragmented and apoptotic bodies were formed.
Incubation with 12.46 ìg/mL of-terpineol for
24 hours can increase the number of apoptotic
cells compared with control group.
This study showed that -terpineol and
doxorubicin induced HeLa cells apoptosis. The
EC50 value of-terpineol and doxorubicin were
13.12 and 5.90 g/mL, respectively. It is
indicated that in these concentration,-terpineol
and doxorubicin had caused 50% of HeLa cells
apoptosis. The mechanism of apoptotic
induction by doxorubicin is reported by
stimulation of a p53-independent apoptosis
through activating caspase-3 in cancer cells.20
The ability to induce apoptosis of cancer
cells is a fundamental starting point in the
development of effective chemotherapeutic
agents. The rate of apoptosis has a significant
influence on the life span of normal and cancer
cells. Modulation of apoptosis is very useful in
the prevention and therapy of cancer. 21
Selectivity has become an important point in
the treatment of cancer. The process of cell death
by apoptosis does not cause inflammation
responses and can reduce side effects of the
drugs in cancer patients. 22 Expression of
apoptosis regulatory protein is necessary to
understand the molecular mechanism of
apoptosis stimulation.
Cell cycle analysis showed that most of
HeLa cells treated with -terpineol were
accumulated in the G0/G1 phase. The highest
number of cells (52.78%) accumulated in G0/
G1 phase was reached with -terpineol
concentration of 6.23 g/mL, whereas in the
untreated control, the number of cell in the G0/
G1 phase was as much as 40.87%. This
illustrated that G0/G1 phase was the longest
phase experienced by cells, and this is why the
cells were accumulated on that phase.20
No significant difference on cell cycle was
observed between -terpineol with concen-
trations of 6.23 g/mL and 12.46 g/mL with
the control group. However, the data showed a
trend of increasing accumulation of cell cycle
in the G0/G1 phase in cells treated with 6.23
g/mL of -terpineol compared to controls.
However, treatment with 12.46 ìg/mL of á-
terpineol showed that most of the cells were
accumulated in sub G0/G1 phase. Those results
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showed that treatment with -terpineol for 24
hours caused the cells to undergo apoptosis.
Study in lymphoma cells U937-GTP showed
that -terpineol induced the inhibition of cell
cycle in G0/G1. That study reported that the
number of cells in G0/G1 phase in treatment
and control were 55% and 42%, respectively.8
In HeLa cells,-terpineol inhibited TNF
and NF-kB translocation into cell nucleus.
Inhibition of NF-kB activation can result in the
reduction of cyclin D expression, an important
protein in the induction of G phase of cell
cycle.8,23 In MCF-7 cells, incubation with -
terpineol for 6 hours had managed to regulate
NF-kB which is associated with IL-1, IL1R1,
IFNG, ITK, EGFR, AKT1S1, TNIK, TRlg
FDD1, BAG1 and BAG3 genes.8 As a result, it
is important to conduct further study on the
influence of-terpineol isolated from pine tree
sap in molecular level.
CONCLUSION
In conclusion, -terpineol is potential as
an anticancer against HeLa cell through its
ability to induce cell apoptosis and to inhibit
the cell cycle at G1 phase. Further study will
be conducted to evaluate the molecular
mechanism of this compund as anticancer. Study
its cytotoxicity on normal cell will be also
conducted.
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